Superantigens: microbial agents that corrupt immunity

Microbial Superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet infectious diseases 2002-03, Vol.2 (3), p.156-162
Hauptverfasser: Llewelyn, Martin, Cohen, Jon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 162
container_issue 3
container_start_page 156
container_title The Lancet infectious diseases
container_volume 2
creator Llewelyn, Martin
Cohen, Jon
description Microbial Superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock syndromes. It is now apparent that Superantigens have a wider role in the pathology of infectious diseases than has previously been appreciated. Staphylococcus aureus and Streptococcus pyogenes together produce 19 different Superantigens. The range of microorganisms known to produce Superantigens has expanded to include Gram negative bacteria, mycoplasma, and viruses. Research is beginning to shed light on the more subtle parts these molecules play in causing disease and to produce some real possibilities for specific treatment of superantigen-induced toxicity. We aim to highlight these new developments and review the science behind these fascinating molecules.
doi_str_mv 10.1016/S1473-3099(02)00222-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_201593779</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309902002220</els_id><sourcerecordid>1662415841</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-da510d2078b7f6576eba97264a090ac9551c9347829ab19b5254944862c7203a3</originalsourceid><addsrcrecordid>eNqFkEtLAzEQgIMotlZ_grJ40sPqJJtsNl5Eii8oeKieQzabakr3YZIV-u9NdwsePc0wfPP6EDrHcIMB57dLTHmWZiDEFZBrAEJICgdoGss0pZTxwyEfkQk68X4NgDkGeowmGAtKccGmiC37zjjVBPtpGn-X1Fa7trRqk6hYCD4JXyokunWu70Ji67pvbNieoqOV2nhzto8z9PH0-D5_SRdvz6_zh0WqKYWQVophqAjwouSrnPHclEpwklMFApQWjGEtMsoLIlSJRckIo_GwIieaE8hUNkOX49zOtd-98UGu2941caUkgJnIOBcRYiMUL_femZXsnK2V20oMcudKDq7kToQEIgdXEmLfxX54X9am-uvay4nA_QiY-OKPNU56bU2jTWWd0UFWrf1nxS_zona0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201593779</pqid></control><display><type>article</type><title>Superantigens: microbial agents that corrupt immunity</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>ProQuest Central UK/Ireland</source><creator>Llewelyn, Martin ; Cohen, Jon</creator><creatorcontrib>Llewelyn, Martin ; Cohen, Jon</creatorcontrib><description>Microbial Superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock syndromes. It is now apparent that Superantigens have a wider role in the pathology of infectious diseases than has previously been appreciated. Staphylococcus aureus and Streptococcus pyogenes together produce 19 different Superantigens. The range of microorganisms known to produce Superantigens has expanded to include Gram negative bacteria, mycoplasma, and viruses. Research is beginning to shed light on the more subtle parts these molecules play in causing disease and to produce some real possibilities for specific treatment of superantigen-induced toxicity. We aim to highlight these new developments and review the science behind these fascinating molecules.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(02)00222-0</identifier><identifier>PMID: 11944185</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Antibodies, Bacterial - therapeutic use ; Bacterial Toxins - immunology ; Biological Warfare ; Communicable Diseases - complications ; Communicable Diseases - therapy ; Enterotoxins - immunology ; Exotoxins - immunology ; Gram-Negative Bacteria - immunology ; Humans ; Infectious diseases ; Microorganisms ; Mycoplasma - immunology ; Sepsis - immunology ; Shock, Septic - immunology ; Shock, Septic - therapy ; Staphylococcal Infections - immunology ; Streptococcal Infections - immunology ; Superantigens - immunology ; Viruses - immunology</subject><ispartof>The Lancet infectious diseases, 2002-03, Vol.2 (3), p.156-162</ispartof><rights>2002 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Mar 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-da510d2078b7f6576eba97264a090ac9551c9347829ab19b5254944862c7203a3</citedby><cites>FETCH-LOGICAL-c440t-da510d2078b7f6576eba97264a090ac9551c9347829ab19b5254944862c7203a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/201593779?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994,64384,64388,72240</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11944185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Llewelyn, Martin</creatorcontrib><creatorcontrib>Cohen, Jon</creatorcontrib><title>Superantigens: microbial agents that corrupt immunity</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Microbial Superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock syndromes. It is now apparent that Superantigens have a wider role in the pathology of infectious diseases than has previously been appreciated. Staphylococcus aureus and Streptococcus pyogenes together produce 19 different Superantigens. The range of microorganisms known to produce Superantigens has expanded to include Gram negative bacteria, mycoplasma, and viruses. Research is beginning to shed light on the more subtle parts these molecules play in causing disease and to produce some real possibilities for specific treatment of superantigen-induced toxicity. We aim to highlight these new developments and review the science behind these fascinating molecules.</description><subject>Animals</subject><subject>Antibodies, Bacterial - therapeutic use</subject><subject>Bacterial Toxins - immunology</subject><subject>Biological Warfare</subject><subject>Communicable Diseases - complications</subject><subject>Communicable Diseases - therapy</subject><subject>Enterotoxins - immunology</subject><subject>Exotoxins - immunology</subject><subject>Gram-Negative Bacteria - immunology</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Microorganisms</subject><subject>Mycoplasma - immunology</subject><subject>Sepsis - immunology</subject><subject>Shock, Septic - immunology</subject><subject>Shock, Septic - therapy</subject><subject>Staphylococcal Infections - immunology</subject><subject>Streptococcal Infections - immunology</subject><subject>Superantigens - immunology</subject><subject>Viruses - immunology</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkEtLAzEQgIMotlZ_grJ40sPqJJtsNl5Eii8oeKieQzabakr3YZIV-u9NdwsePc0wfPP6EDrHcIMB57dLTHmWZiDEFZBrAEJICgdoGss0pZTxwyEfkQk68X4NgDkGeowmGAtKccGmiC37zjjVBPtpGn-X1Fa7trRqk6hYCD4JXyokunWu70Ji67pvbNieoqOV2nhzto8z9PH0-D5_SRdvz6_zh0WqKYWQVophqAjwouSrnPHclEpwklMFApQWjGEtMsoLIlSJRckIo_GwIieaE8hUNkOX49zOtd-98UGu2941caUkgJnIOBcRYiMUL_femZXsnK2V20oMcudKDq7kToQEIgdXEmLfxX54X9am-uvay4nA_QiY-OKPNU56bU2jTWWd0UFWrf1nxS_zona0</recordid><startdate>20020301</startdate><enddate>20020301</enddate><creator>Llewelyn, Martin</creator><creator>Cohen, Jon</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20020301</creationdate><title>Superantigens: microbial agents that corrupt immunity</title><author>Llewelyn, Martin ; Cohen, Jon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-da510d2078b7f6576eba97264a090ac9551c9347829ab19b5254944862c7203a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Animals</topic><topic>Antibodies, Bacterial - therapeutic use</topic><topic>Bacterial Toxins - immunology</topic><topic>Biological Warfare</topic><topic>Communicable Diseases - complications</topic><topic>Communicable Diseases - therapy</topic><topic>Enterotoxins - immunology</topic><topic>Exotoxins - immunology</topic><topic>Gram-Negative Bacteria - immunology</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Microorganisms</topic><topic>Mycoplasma - immunology</topic><topic>Sepsis - immunology</topic><topic>Shock, Septic - immunology</topic><topic>Shock, Septic - therapy</topic><topic>Staphylococcal Infections - immunology</topic><topic>Streptococcal Infections - immunology</topic><topic>Superantigens - immunology</topic><topic>Viruses - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Llewelyn, Martin</creatorcontrib><creatorcontrib>Cohen, Jon</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Llewelyn, Martin</au><au>Cohen, Jon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Superantigens: microbial agents that corrupt immunity</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2002-03-01</date><risdate>2002</risdate><volume>2</volume><issue>3</issue><spage>156</spage><epage>162</epage><pages>156-162</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Microbial Superantigens are a family of protein exotoxins that share the ability to trigger excessive and aberrant activation of T cells. The best characterised are the staphylococcal enterotoxins and the streptococcal pyrogenic exotoxins that trigger the staphylococcal and streptococcal toxic shock syndromes. It is now apparent that Superantigens have a wider role in the pathology of infectious diseases than has previously been appreciated. Staphylococcus aureus and Streptococcus pyogenes together produce 19 different Superantigens. The range of microorganisms known to produce Superantigens has expanded to include Gram negative bacteria, mycoplasma, and viruses. Research is beginning to shed light on the more subtle parts these molecules play in causing disease and to produce some real possibilities for specific treatment of superantigen-induced toxicity. We aim to highlight these new developments and review the science behind these fascinating molecules.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>11944185</pmid><doi>10.1016/S1473-3099(02)00222-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1473-3099
ispartof The Lancet infectious diseases, 2002-03, Vol.2 (3), p.156-162
issn 1473-3099
1474-4457
language eng
recordid cdi_proquest_journals_201593779
source MEDLINE; ScienceDirect Journals (5 years ago - present); ProQuest Central UK/Ireland
subjects Animals
Antibodies, Bacterial - therapeutic use
Bacterial Toxins - immunology
Biological Warfare
Communicable Diseases - complications
Communicable Diseases - therapy
Enterotoxins - immunology
Exotoxins - immunology
Gram-Negative Bacteria - immunology
Humans
Infectious diseases
Microorganisms
Mycoplasma - immunology
Sepsis - immunology
Shock, Septic - immunology
Shock, Septic - therapy
Staphylococcal Infections - immunology
Streptococcal Infections - immunology
Superantigens - immunology
Viruses - immunology
title Superantigens: microbial agents that corrupt immunity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T21%3A17%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Superantigens:%20microbial%20agents%20that%20corrupt%20immunity&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Llewelyn,%20Martin&rft.date=2002-03-01&rft.volume=2&rft.issue=3&rft.spage=156&rft.epage=162&rft.pages=156-162&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(02)00222-0&rft_dat=%3Cproquest_cross%3E1662415841%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201593779&rft_id=info:pmid/11944185&rft_els_id=S1473309902002220&rfr_iscdi=true